Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma.

Publication ,  Journal Article
Berdahl, JP; Khatana, AK; Katz, LJ; Herndon, L; Layton, AJ; Yu, TM; Bauer, MJ; Cantor, LB
Published in: J Med Econ
July 2017

AIM: Patients with open-angle glaucoma (OAG) whose intraocular pressure is not adequately controlled by one medication have several treatment options in the US. This analysis evaluated direct costs of unilateral eye treatment with two trabecular micro-bypass stents (two iStents) compared to selective laser trabeculoplasty (SLT) or medications only. MATERIALS AND METHODS: A population-based, annual state-transition, probabilistic, cost-of-care model was used to assess OAG-related costs over 5 years. Patients were modeled to initiate treatment in year zero with two iStents, SLT, or medications only. In years 1-5, patients could remain on initial treatment or move to another treatment option(s), or filtration surgery. Treatment strategy change probabilities were identified by a clinician panel. Direct costs were included for drugs, procedures, and complications. RESULTS: The projected average cumulative cost at 5 years was lower in the two-stent treatment arm ($4,420) compared to the SLT arm ($4,730) or medications-only arm ($6,217). Initial year-zero costs were higher with two iStents ($2,810) than with SLT ($842) or medications only ($996). Average marginal annual costs in years 1-5 were $322 for two iStents, $777 for SLT, and $1,044 for medications only. The cumulative cost differences between two iStents vs SLT or medications only decreased over time, with breakeven by 5 or 3 years post-initiation, respectively. By year 5, cumulative savings with two iStents over SLT or medications only was $309 or $1,797, respectively. LIMITATIONS: This analysis relies on clinical expert panel opinion and would benefit from real-world evidence on use of multiple procedures and treatment switching after two-stent treatment, SLT, or polypharmaceutical initial approaches. CONCLUSIONS: Despite higher costs in year zero, annual costs thereafter were lowest in the two-stent treatment arm. Two-stent treatment may reduce OAG-related health resource use, leading to direct savings, especially over medications only or at longer time horizons.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Med Econ

DOI

EISSN

1941-837X

Publication Date

July 2017

Volume

20

Issue

7

Start / End Page

760 / 766

Location

England

Related Subject Headings

  • Trabeculectomy
  • Stents
  • Models, Economic
  • Markov Chains
  • Male
  • Laser Therapy
  • Intraocular Pressure
  • Humans
  • Health Policy & Services
  • Glaucoma, Open-Angle
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Berdahl, J. P., Khatana, A. K., Katz, L. J., Herndon, L., Layton, A. J., Yu, T. M., … Cantor, L. B. (2017). Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma. J Med Econ, 20(7), 760–766. https://doi.org/10.1080/13696998.2017.1327439
Berdahl, John P., Anup K. Khatana, L Jay Katz, Leon Herndon, Andrew J. Layton, Tiffany M. Yu, Matthew J. Bauer, and Louis B. Cantor. “Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma.J Med Econ 20, no. 7 (July 2017): 760–66. https://doi.org/10.1080/13696998.2017.1327439.
Berdahl, John P., et al. “Cost-comparison of two trabecular micro-bypass stents versus selective laser trabeculoplasty or medications only for intraocular pressure control for patients with open-angle glaucoma.J Med Econ, vol. 20, no. 7, July 2017, pp. 760–66. Pubmed, doi:10.1080/13696998.2017.1327439.

Published In

J Med Econ

DOI

EISSN

1941-837X

Publication Date

July 2017

Volume

20

Issue

7

Start / End Page

760 / 766

Location

England

Related Subject Headings

  • Trabeculectomy
  • Stents
  • Models, Economic
  • Markov Chains
  • Male
  • Laser Therapy
  • Intraocular Pressure
  • Humans
  • Health Policy & Services
  • Glaucoma, Open-Angle